Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

New Insights on the Role of Surgery for the Breast Primary Tumor in Patients Presenting With Stage IV Disease

New Insights on the Role of Surgery for the Breast Primary Tumor in Patients Presenting With... Curr Breast Cancer Rep (2017) 9:137–147 DOI 10.1007/s12609-017-0241-z LOCAL-REGIONAL EVALUATION AND THERAPY (EP MAMOUNAS, SECTION EDITOR) New Insights on the Role of Surgery for the Breast Primary Tumor in Patients Presenting With Stage IV Disease 1,2 1,2 Anvy Nguyen & Tari A. King Published online: 18 April 2017 Springer Science+Business Media New York 2017 Abstract Introduction Purpose of Review Though systemic therapy has been the standard treatment for patients with de novo metastatic breast Despite the significant progress that has been achieved in cancer, a large number of retrospective studies demonstrate breast cancer screening and early diagnosis, 5–10% of breast that resection of the primary tumor is associated with im- cancer patients in the USA will present with distant metastasis proved survival. Here, we review the potential rationale for at diagnosis, i.e., de novo metastatic disease [1, 2]. While the resection, available retrospective and prospective data, and overwhelming majority of metastatic breast cancer cases are challenges in applying these data in clinical practice. considered to be treatable but not curable, the natural history Recent Findings Results from prospective trials to date are of de novo stage IV breast cancer is notably different than limited. The only published randomized controlled http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Breast Cancer Reports Springer Journals

New Insights on the Role of Surgery for the Breast Primary Tumor in Patients Presenting With Stage IV Disease

Current Breast Cancer Reports , Volume 9 (2) – Apr 18, 2017

Loading next page...
 
/lp/springer-journals/new-insights-on-the-role-of-surgery-for-the-breast-primary-tumor-in-RVV9n7kewl

References (69)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Oncology; Internal Medicine; Surgical Oncology
ISSN
1943-4588
eISSN
1943-4596
DOI
10.1007/s12609-017-0241-z
Publisher site
See Article on Publisher Site

Abstract

Curr Breast Cancer Rep (2017) 9:137–147 DOI 10.1007/s12609-017-0241-z LOCAL-REGIONAL EVALUATION AND THERAPY (EP MAMOUNAS, SECTION EDITOR) New Insights on the Role of Surgery for the Breast Primary Tumor in Patients Presenting With Stage IV Disease 1,2 1,2 Anvy Nguyen & Tari A. King Published online: 18 April 2017 Springer Science+Business Media New York 2017 Abstract Introduction Purpose of Review Though systemic therapy has been the standard treatment for patients with de novo metastatic breast Despite the significant progress that has been achieved in cancer, a large number of retrospective studies demonstrate breast cancer screening and early diagnosis, 5–10% of breast that resection of the primary tumor is associated with im- cancer patients in the USA will present with distant metastasis proved survival. Here, we review the potential rationale for at diagnosis, i.e., de novo metastatic disease [1, 2]. While the resection, available retrospective and prospective data, and overwhelming majority of metastatic breast cancer cases are challenges in applying these data in clinical practice. considered to be treatable but not curable, the natural history Recent Findings Results from prospective trials to date are of de novo stage IV breast cancer is notably different than limited. The only published randomized controlled

Journal

Current Breast Cancer ReportsSpringer Journals

Published: Apr 18, 2017

There are no references for this article.